Have a personal or library account? Click to login
Are current systemic endothelial anti-inflammatory therapies effective/safe, and only in secondary prophylaxis? Cover

Are current systemic endothelial anti-inflammatory therapies effective/safe, and only in secondary prophylaxis?

Romanian Journal of Cardiology
Volume 35 (2025): Issue 3 (September 2025)
By: Lucian Petrescu and  Ciprian Rachieru  
Open Access
|Sep 2025
DOI: https://doi.org/10.2478/rjc-2025-0029 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X
Journal RSS Feed
Language: English
Page range: 159 - 164
Published on: Sep 30, 2025
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Atherosclerosis/atherothrombosis,
“vulnerable” plaque,
residual inflammatory risk,
lipid-lowering treatments,
primary endothelial anti-inflammatory treatments,
primary non-anti-inflammatory therapies,
secondary atherothrombotic prevention studies with anti-inflammatories
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Cardiology,
Surgery,
Cardiac surgery,
Pediatrics and juvenile medicine,
Paediatric cardiology

© 2025 Lucian Petrescu, Ciprian Rachieru, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 35 (2025): Issue 3 (September 2025)Next article